Charles Schwab’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,505
| Closed | -$40.5K | – | 3511 |
|
|
2024
Q3 | $40.5K | Hold |
12,505
| – | – | ﹤0.01% | 3434 |
|
|
2024
Q2 | $37.5K | Hold |
12,505
| – | – | ﹤0.01% | 3543 |
|
|
2024
Q1 | $58.1K | Hold |
12,505
| – | – | ﹤0.01% | 3353 |
|
|
2023
Q4 | $51.8K | Hold |
12,505
| – | – | ﹤0.01% | 3400 |
|
|
2023
Q3 | $37.5K | Hold |
12,505
| – | – | ﹤0.01% | 3431 |
|
|
2023
Q2 | $30.8K | Sell |
12,505
-61,410
| -83% | -$151K | ﹤0.01% | 3501 |
|
|
2023
Q1 | $167K | Buy |
73,915
+12,505
| +20% | +$28.3K | ﹤0.01% | 3183 |
|
|
2022
Q4 | $214K | Sell |
61,410
-9,105
| -13% | -$31.8K | ﹤0.01% | 3174 |
|
|
2022
Q3 | $2.61M | Sell |
70,515
-1,991
| -3% | -$73.7K | ﹤0.01% | 2504 |
|
|
2022
Q2 | $1.38M | Buy |
72,506
+5,510
| +8% | +$105K | ﹤0.01% | 2683 |
|
|
2022
Q1 | $1.81M | Buy |
66,996
+21,621
| +48% | +$584K | ﹤0.01% | 2677 |
|
|
2021
Q4 | $1.02M | Buy |
45,375
+4,118
| +10% | +$92.8K | ﹤0.01% | 2902 |
|
|
2021
Q3 | $1.08M | Sell |
41,257
-57,910
| -58% | -$1.52M | ﹤0.01% | 2846 |
|
|
2021
Q2 | $3.18M | Buy |
99,167
+4,605
| +5% | +$147K | ﹤0.01% | 2565 |
|
|
2021
Q1 | $3.33M | Buy |
94,562
+1,734
| +2% | +$61.1K | ﹤0.01% | 2491 |
|
|
2020
Q4 | $2.98M | Buy |
92,828
+3,392
| +4% | +$109K | ﹤0.01% | 2461 |
|
|
2020
Q3 | $3.37M | Sell |
89,436
-620
| -0.7% | -$23.3K | ﹤0.01% | 2267 |
|
|
2020
Q2 | $4.03M | Buy |
90,056
+36,728
| +69% | +$1.64M | ﹤0.01% | 2126 |
|
|
2020
Q1 | $1.82M | Buy |
53,328
+4,141
| +8% | +$141K | ﹤0.01% | 2308 |
|
|
2019
Q4 | $1.92M | Buy |
+49,187
| New | +$1.92M | ﹤0.01% | 2433 |
|